Listed

Viemed Healthcare, Inc.

VMDNasdaqCIK 1729149HealthcareFiscal year ends Dec 31

Reports and events: 134 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Viemed Healthcare, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0117:03 ET10-QQuarterly reportPeriod 2023-09-300001729149-23-000161
2023-11-0117:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-23-000160
2023-08-1017:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-23-000113
2023-08-0916:19 ET10-QQuarterly reportPeriod 2023-06-300001729149-23-000111
2023-08-0916:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-23-000110
2023-08-0217:09 ET8-K/A9.01 Financial statements and exhibits0001729149-23-000103
2023-06-1317:26 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-23-000091
2023-06-0116:12 ET8-K2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-23-000086
2023-05-1817:21 ETSC 13D/AOwnership report, active investor, amended0001781905-23-000005
2023-05-0917:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-23-000065
2023-05-0817:23 ET10-QQuarterly reportPeriod 2023-03-310001729149-23-000062
2023-05-0817:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-23-000061
2023-04-2809:00 ETDEF 14AProxy statementPeriod 2023-04-280001729149-23-000053
2023-04-1917:38 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-23-000050
2023-03-0317:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-23-000042
2023-03-0216:56 ET10-KAnnual reportPeriod 2022-12-310001729149-23-000040
2023-03-0216:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-23-000039
2023-01-2309:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-23-000032
2023-01-1209:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-23-000004
2022-11-2916:06 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-22-000106
2022-11-0316:29 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-22-000101
2022-11-0116:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-22-000098
2022-11-0116:36 ET10-QQuarterly reportPeriod 2022-09-300001729149-22-000097
2022-08-0518:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-22-000076
2022-08-0217:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-22-000072
2022-08-0217:04 ET10-QQuarterly reportPeriod 2022-06-300001729149-22-000069
2022-08-0109:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-22-000064
2022-07-0516:19 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-22-000062
2022-06-0916:57 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-22-000058
2022-05-1607:31 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001729149-22-000055
2022-05-0414:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-22-000041
2022-05-0317:13 ET10-QQuarterly reportPeriod 2022-03-310001729149-22-000038
2022-05-0317:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-22-000036
2022-04-2910:44 ETDEF 14AProxy statementPeriod 2022-04-290001729149-22-000031
2022-03-0816:21 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001729149-22-000025
2022-03-0716:43 ET10-KAnnual reportPeriod 2021-12-310001729149-22-000020
2022-03-0716:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-22-000019
2021-11-0316:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-21-000139
2021-11-0217:44 ET10-QQuarterly reportPeriod 2021-09-300001729149-21-000137
2021-11-0217:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-21-000136
2021-09-1615:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-21-000133
2021-08-0617:41 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-21-000108
2021-08-0317:33 ET10-QQuarterly reportPeriod 2021-06-300001729149-21-000106
2021-08-0217:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-21-000105
2021-06-1016:37 ET8-K3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-21-000101
2021-05-2408:13 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-21-000099
2021-05-0616:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001729149-21-000072
2021-05-0317:29 ET10-QQuarterly reportPeriod 2021-03-310001729149-21-000069
2021-05-0317:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001729149-21-000068
2021-04-3016:06 ETDEF 14AProxy statementPeriod 2021-06-100001729149-21-000061

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 19:03 ET. Listed shows no prices and gives no investment advice.